Trial ID or NCT#

NCT03547206

Status

not recruiting iconNOT RECRUITING

Purpose

This study is designed as a double-masked, randomized, placebo-controlled, pivotal, clinical study to evaluate the efficacy and safety of subcutaneous (SC) administration of RPh201 in participants with previous NAION. All participants enrolled in the study will have a documented history of NAION for at least 12 months and at most, five years prior to enrollment.

Official Title

A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION

Eligibility Criteria

Ages Eligible for Study: Older than 50 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Y. Joyce Liao, MD, PhD
Y. Joyce Liao, MD, PhD
Neuro-ophthalmology specialist
Associate Professor of Ophthalmology and of Neurology at the Stanford University Medical Center
Heather E. Moss, MD, PhD
Heather E. Moss, MD, PhD
Neuro-ophthalmology specialist
Associate Professor of Ophthalmology at the Stanford University Medical Center
Shannon Beres, MD
Neuro-ophthalmology specialist, General neurologist
Clinical Assistant Professor, Neurology & Neurological Sciences Clinical Assistant Professor, Ophthalmology

Contact us to find out if this trial is right for you.

CONTACT

Mariana Nunez
(650) 497-7846